Science Exchange, the world’s leading R&D services marketplace, announced a collaboration with Navitas Life Sciences to offer online access to its suite of service offerings across consulting, support for phase I-IV studies, bioequivalence and bioavailability (BA/BE) studies, and other biosimilars sudies.

Navitas Life Sciences will also provide access to its Functional Service Provider (FSP / BPO) services across regulatory, artwork and labeling, pharmacovigilance / individual case safety reports (PV/ICSR) processing, reporting and signal detection and technology through a proven deliverables/unit pricing model.  

Navitas Life Sciences is a global consulting, technology and services provider, whose mission is to enable insights-driven services that will deliver improved outcomes for the Life Sciences Industry.